# Catheter Precision, Inc. (VTAK) — restructuring/exchange_offer [pending]
Source: SEC API (secapi.ai) · situation sit_cd5a3a1adf7a940b7f95 · retrieved 2026-08-11T16:11:12.940Z

## Overview
Catheter Precision, Inc. is a medical device company that manufactures surgical and medical instruments and apparatus.

Catheter Precision, Inc. consummated the closing of the Series C-4 Convertible Preferred Stock offering on July 30, 2026, issuing 2,821 shares at a stated value of $1,000 per share for aggregate gross proceeds of $2,821,000. The shares were issued pursuant to an Additional Investment Right under the Securities Purchase Agreement dated March 9, 2026. The Series C-4 Preferred Stock ranks senior to Common Stock with respect to dividends and liquidation preferences, and is convertible into Common Stock at a conversion price of $0.35 per share, subject to adjustment. The Company intends to use the net proceeds for working capital, general corporate purposes, and redemption of all outstanding Series B Convertible Preferred Stock.

## Terms
- Counterparty: Participating Buyers (accredited investors) · Deal value: $2.8M · Consideration: cash · Price/share: $1000

## Key dates
- Announced 2026-07-15 · Vote 2026-04-15

## Timeline
- 2026-07-15 · 8-K (0001437749-26-023639): 8-K - Catheter Precision, Inc. — *Catheter Precision, Inc. is a medical device company that manufactures surgical and medical instruments and apparatus.* Catheter Precision, Inc. consummated the closing of its Series C-3 Convertible Preferred Stock offering on July 15, 2026, issuing 3,470 shares with a stated value of $1,000 per share for aggregate gross proceeds of $3,470,000. The Series C-3 Preferred Stock is convertible into common stock at an initial conversion price of $0.632 per share, subject to a floor price of $0.35 per share (waivable at the Company's discretion) and customary anti-dilution adjustments. The offering was conducted pursuant to Securities Purchase Agreements dated February 6, 2026 and March 9, 2026, and required stockholder approval obtained at a Special Meeting on April 15, 2026. The Company intends to use net proceeds for working capital, loan repayment, and general corporate purposes.
  https://www.sec.gov/Archives/edgar/data/1716621/0001437749-26-023639.txt
- 2026-07-31 · 8-K (0001437749-26-025252): 8-K - Catheter Precision, Inc. — *Catheter Precision, Inc. is a medical device company that manufactures surgical and medical instruments and apparatus.* Catheter Precision, Inc. consummated the closing of the Series C-4 Convertible Preferred Stock offering on July 30, 2026, issuing 2,821 shares at a stated value of $1,000 per share for aggregate gross proceeds of $2,821,000. The shares were issued pursuant to an Additional Investment Right under the Securities Purchase Agreement dated March 9, 2026. The Series C-4 Preferred Stock ranks senior to Common Stock with respect to dividends and liquidation preferences, and is convertible into Common Stock at a conversion price of $0.35 per share, subject to adjustment. The Company intends to use the net proceeds for working capital, general corporate purposes, and redemption of all outstanding Series B Convertible Preferred Stock.
  https://www.sec.gov/Archives/edgar/data/1716621/0001437749-26-025252.txt

## Citations
- 0001437749-26-023639 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000143774926023639
- 0001437749-26-025252 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000143774926025252